Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030193 (
pain
)
261,466
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Women with no immunity to Toxoplasma organisms acquire toxoplasmosis during pregnancy; the infection spreads to the fetus by transplacental transmission. 2. Blurred vision, floaters,
photopsia
,
pain
, and redness are common complaints of the active retinochoroiditis. 3. The diagnosis of ocular toxoplasmosis can be confirmed by blood tests, the most common being the indirect fluorescent antibody (IFA) and the enzyme-linked immunosorbent assay (ELISA).
...
PMID:Ocular toxoplasmosis. 830 76
We prospectively evaluated the frequency, time-course and predisposing factors of phantom eye syndrome in 53 patients who underwent surgical eye amputation to cure ocular cancer. Before surgery, patients were classified as Group I (n = 25) if they had no history of headache or Group II (n = 28) if they were headache sufferers. Three clinical patterns were distinguished: phantom
pain
, non-painful phantom phenomena and photopsias. Their symptoms developed 7 days to 6 months after surgery, with peak incidence after 6 months (
photopsia
43%; phantom
pain
28%; non-painful phantom phenomena 62%). Phantom eye syndrome was more common in headache sufferers than in non-headache subjects. Headache sufferers were more prone to phantom
pain
, but more so to non-painful phenomena and photopsias. These findings are in accord with our previous results indicating that primary headache sufferers are prone to phantom tooth
pain
.
...
PMID:Phantom eye: features and prevalence. The predisposing role of headache. 920 70
Idiopathic intracranial hypertension (IIH) is defined as a syndrome of increased intracranial pressure without causative lesions on magnetic resonance imaging. The symptoms of IIH patients are headache, transient visual obscurations,
photopsia
, retrobulbar
pain
, diplopia, visual loss and papilledema. Management of intracranial hypertension is initially medical, using a combination of managed weight body reduction and diuretic, non-steroid and steroid therapy. Surgical therapy may be required to stabilize vision.
...
PMID:[Idiopathic intracranial hypertension and organ of vision]. 2334 7